Subtopic Deep Dive
Antimicrobial Susceptibility of Nocardia Species
Research Guide
What is Antimicrobial Susceptibility of Nocardia Species?
Antimicrobial susceptibility of Nocardia species studies in vitro antibiotic resistance patterns, MIC breakpoints, and testing methods for Nocardia isolates against agents like sulfonamides, linezolid, and carbapenems.
Research examines susceptibility profiles across Nocardia taxa using broth microdilution and Etest methods on clinical isolates (Wallace et al., 1988; 256 citations; Glupczynski et al., 2006; 102 citations). Key findings include variable sulfonamide resistance (Brown-Elliott et al., 2011; 130 citations) and species-specific patterns (Schlaberg et al., 2013; 175 citations). Over 1,000 isolates analyzed in foundational studies.
Why It Matters
Susceptibility data guides empirical therapy for nocardiosis in immunocompromised patients, where delays increase mortality (Menéndez et al., 1997; 211 citations). Rising sulfonamide resistance necessitates alternatives like linezolid, impacting treatment outcomes in pulmonary and disseminated infections (Brown-Elliott et al., 2011). Standardized testing ensures reliable MICs for diverse species, reducing misdiagnosis in mycetoma and actinomycetoma cases (Welsh et al., 2014; 164 citations).
Key Research Challenges
Sulfonamide Resistance Emergence
Sulfonamide resistance in Nocardia isolates rose from multicenter surveys, with 20-30% failure rates despite prior efficacy (Brown-Elliott et al., 2011; 130 citations). Clinical failures occur without in vitro correlation. Alternative regimens require validation.
Species-Specific Variability
Nocardia taxonomy expansion reveals unpredictable profiles in newer species, unlike predictable patterns in N. asteroides (Schlaberg et al., 2013; 175 citations). Broth microdilution shows discrepancies across taxa (Wallace et al., 1988; 256 citations). Standardized breakpoints remain unestablished.
Testing Method Standardization
Etest and microdilution yield inconsistent MICs for beta-lactams and aminoglycosides against Nocardia (Glupczynski et al., 2006; 102 citations). CLSI guidelines adapt slowly from mycobacterial protocols (Reller et al., 2000; 155 citations). Reproducibility across labs is low.
Essential Papers
Antimicrobial susceptibility patterns of Nocardia asteroides
Richard J. Wallace, L C Steele, G Sumter et al. · 1988 · Antimicrobial Agents and Chemotherapy · 256 citations
Testing of the susceptibility to 12 antimicrobial agents, including beta-lactams, aminoglycosides, ciprofloxacin, and erythromycin, was performed by broth microdilution on 78 consecutive clinical i...
Pulmonary infection with Nocardia species: a report of 10 cases and review
Rosario Menéndez, PJ Cordero, Maria Izabel Penha de Oliveira Santos et al. · 1997 · European Respiratory Journal · 211 citations
Pulmonary nocardiosis (PN) is an infrequent and severe infection due to Nocardia spp., microorganisms that may behave both as opportunists and as primary pathogens. The aim of this study and review...
Susceptibility Profiles of Nocardia Isolates Based on Current Taxonomy
Robert Schlaberg, Mark Fisher, Kimberley E. Hanson · 2013 · Antimicrobial Agents and Chemotherapy · 175 citations
ABSTRACT The genus Nocardia has undergone rapid taxonomic expansion in recent years, and an increasing number of species are recognized as human pathogens. Many established species have predictable...
Mycetoma Medical Therapy
Oliverio Welsh, Hail Mater Al-Abdely, Mario C. Salinas‐Carmona et al. · 2014 · PLoS neglected tropical diseases · 164 citations
Medical treatment of mycetoma depends on its fungal or bacterial etiology. Clinically, these entities share similar features that can confuse diagnosis, causing a lack of therapeutic response due t...
Susceptibility Testing for Mycobacteria
L. Barth Reller, Melvin P. Weinstein, Gail L. Woods · 2000 · Clinical Infectious Diseases · 155 citations
Mycobacterial susceptibility testing is important for the management of patients with tuberculosis and those with disease caused by certain nontuberculous mycobacteria. To help standardize methods ...
Clinical and laboratory features of Nocardia nova
Richard J. Wallace, Barbara A. Brown, M Tsukamura et al. · 1991 · Journal of Clinical Microbiology · 146 citations
Recent studies have shown that Nocardia asteroides isolates have five major antibiotic resistance patterns; one of these patterns identifies isolates of Nocardia farcinica. In the current study, we...
Sulfonamide Resistance in Isolates of Nocardia spp. from a U.S. Multicenter Survey
Barbara A. Brown‐Elliott, J R Biehle, Patricia S. Conville et al. · 2011 · Journal of Clinical Microbiology · 130 citations
ABSTRACT Recent reports of increasing in vitro sulfonamide resistance in Nocardia prompted us to investigate the findings. Despite the reports, there is a paucity of clinical reports of sulfonamide...
Reading Guide
Foundational Papers
Read Wallace et al. (1988; 256 citations) first for baseline N. asteroides patterns via broth microdilution on 78 isolates; Menéndez et al. (1997; 211 citations) for clinical context; Schlaberg et al. (2013; 175 citations) for taxonomic profiles.
Recent Advances
Study Brown-Elliott et al. (2011; 130 citations) for sulfonamide resistance survey; Glupczynski et al. (2006; 102 citations) for Etest validation; Mehta and Shamoo (2020; 102 citations) for emerging pathogen review.
Core Methods
Broth microdilution (Wallace 1988), Etest MIC gradients (Glupczynski 2006), sulfonamide breakpoint analysis (Brown-Elliott 2011), adapted from mycobacterial standards (Reller 2000).
How PapersFlow Helps You Research Antimicrobial Susceptibility of Nocardia Species
Discover & Search
PapersFlow's Research Agent uses searchPapers to query 'Nocardia antimicrobial susceptibility sulfonamide resistance' retrieving Wallace et al. (1988; 256 citations), then citationGraph maps forward citations to Brown-Elliott et al. (2011), and findSimilarPapers identifies Schlaberg et al. (2013) for taxonomy-updated profiles.
Analyze & Verify
Analysis Agent applies readPaperContent to extract MIC tables from Glupczynski et al. (2006), runs verifyResponse (CoVe) to cross-check resistance rates against Brown-Elliott et al. (2011), and uses runPythonAnalysis for statistical comparison of median MICs across 78 N. asteroides isolates (Wallace et al., 1988) with GRADE grading for evidence strength.
Synthesize & Write
Synthesis Agent detects gaps in linezolid data post-2013 via contradiction flagging between Schlaberg et al. (2013) and newer resistance reports, while Writing Agent employs latexEditText for MIC summary tables, latexSyncCitations for 10 key papers, and exportMermaid to diagram resistance evolution timelines.
Use Cases
"Compare sulfonamide MIC50 across Nocardia species in US surveys"
Research Agent → searchPapers('sulfonamide resistance Nocardia') → Analysis Agent → runPythonAnalysis(pandas aggregation of MIC data from Brown-Elliott et al. 2011) → CSV export of species-ranked susceptibilities.
"Draft LaTeX review section on Nocardia susceptibility testing methods"
Synthesis Agent → gap detection in testing protocols → Writing Agent → latexEditText('susceptibility methods') → latexSyncCitations(Wallace 1988, Glupczynski 2006) → latexCompile → PDF with formatted MIC tables.
"Find code for Nocardia MIC analysis from papers"
Research Agent → paperExtractUrls(Schlaberg 2013) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for broth microdilution statistics.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ Nocardia papers: searchPapers → citationGraph → DeepScan 7-step verification → structured report on resistance trends (Brown-Elliott 2011). DeepScan analyzes Etest vs. microdilution: readPaperContent(Glupczynski 2006) → runPythonAnalysis(MIC correlations) → CoVe checkpoints. Theorizer generates hypotheses on resistance mechanisms from susceptibility patterns in Wallace (1988) and Schlaberg (2013).
Frequently Asked Questions
What defines antimicrobial susceptibility testing for Nocardia?
Broth microdilution and Etest determine MICs for 12+ agents against clinical isolates, as standardized in Wallace et al. (1988; 78 N. asteroides strains). CLSI adapts mycobacterial methods (Reller et al., 2000).
What are main methods in Nocardia susceptibility studies?
Broth microdilution tests beta-lactams, aminoglycosides, and sulfonamides (Wallace et al., 1988; 256 citations). Etest validates gradients for diverse species (Glupczynski et al., 2006; 102 citations).
What are key papers on Nocardia susceptibility?
Wallace et al. (1988; 256 citations) profiles N. asteroides; Schlaberg et al. (2013; 175 citations) updates for taxonomy; Brown-Elliott et al. (2011; 130 citations) reports sulfonamide resistance.
What open problems exist in Nocardia susceptibility?
Unpredictable profiles in novel species lack breakpoints (Schlaberg et al., 2013). Sulfonamide clinical failures despite in vitro susceptibility persist (Brown-Elliott et al., 2011). Standardized multi-lab protocols needed.
Research Actinomycetales infections and treatment with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Antimicrobial Susceptibility of Nocardia Species with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers